Type 2 & other diabetes

Lymphocytes regulate expression of the SARS‐CoV‐2 cell entry factor ACE2 in the pancreas of T2DM patients

Diabet MedPublished Mechanistic study

Authors' conclusion

Increased blood glucose levels are associated with increased ACE2 expression and an increased number of lymphocytes. At the same time, lymphocytes can promote ACE2 expression.

Study context

Population
Clinical pancreatic samples of T2D patients and diabetic mouse models
Outcome
ACE2 and TMPRSS2 expression in pancreatic cell types
Methodological detailssingle-cell sequencing, bioinformatics analysis, diabetic mouse models
  • Single-cell sequencing
  • Bioinformatics analysis
  • Diabetic mouse models

Main finding

As reported in the abstract

  • ACE2 and TMPRSS2 are expressed in the ducts of the human pancreas
  • T2D can promote co-expression of ACE2 and TMPRSS2 in exocrine ducts, including in the human pancreas
  • Hypothesis: ACE2 expression levels are associated with increased numbers of lymphocytes in vivo

Original publication

Lymphocytes regulate expression of the SARS‐CoV‐2 cell entry factor ACE2 in the pancreas of T2DM patients. Diabet Med. Published 11 April 2023. doi:10.1111/dme.15106

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.